Devyser strengthens U.S. market presence with CMS pricing for PrenatalDetect RHD test
Devyser today announced that the Centers for Medicare & Medicaid Services (CMS) has issued its...
News | July 3, 2018
Devyser is pleased to announce the publication of a new whitepaper Familial Hypercholesterolemia: Genetic Diagnosis and Cascade Testing Using NGS
The 6th in our Expert Review series, this paper is co-authored by Peter Benedek and Kristina Duvefelt, of Karolinska University Hospital, Stockholm.
The paper is a guide to conducting testing using NGS, and the benefits of implementing cascade screening for FH, which is a dominant yet highly underdiagnosed heriditary disorder. Affected individuals are affected by high levels of LDL-cholesterol, and early onset cardiovascular disease and death.
.png)